Regeneron Pharmaceuticals Inc (REGN)
781.46
-22.87
(-2.84%)
USD |
NASDAQ |
Nov 14, 16:00
781.00
-0.46
(-0.06%)
After-Hours: 17:27
Regeneron Pharmaceuticals Total Return Level: 804.33 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 13, 2024 | 804.33 |
| November 12, 2024 | 821.00 |
| November 11, 2024 | 825.68 |
| November 08, 2024 | 828.42 |
| November 07, 2024 | 824.48 |
| November 06, 2024 | 816.65 |
| November 05, 2024 | 829.43 |
| November 04, 2024 | 828.84 |
| November 01, 2024 | 843.60 |
| October 31, 2024 | 838.20 |
| October 30, 2024 | 922.79 |
| October 29, 2024 | 927.33 |
| October 28, 2024 | 928.61 |
| October 25, 2024 | 933.02 |
| October 24, 2024 | 928.90 |
| October 23, 2024 | 941.39 |
| October 22, 2024 | 962.34 |
| October 21, 2024 | 968.50 |
| October 18, 2024 | 990.68 |
| October 17, 2024 | 998.23 |
| October 16, 2024 | 1007.96 |
| October 15, 2024 | 1016.53 |
| October 14, 2024 | 1014.25 |
| October 11, 2024 | 1015.67 |
| October 10, 2024 | 999.02 |
| Date | Value |
|---|---|
| October 09, 2024 | 1012.19 |
| October 08, 2024 | 1005.26 |
| October 07, 2024 | 996.05 |
| October 04, 2024 | 1012.82 |
| October 03, 2024 | 1014.59 |
| October 02, 2024 | 1040.27 |
| October 01, 2024 | 1046.91 |
| September 30, 2024 | 1051.24 |
| September 27, 2024 | 1042.69 |
| September 26, 2024 | 1039.96 |
| September 25, 2024 | 1031.15 |
| September 24, 2024 | 1045.98 |
| September 23, 2024 | 1091.98 |
| September 20, 2024 | 1145.03 |
| September 19, 2024 | 1150.19 |
| September 18, 2024 | 1138.81 |
| September 17, 2024 | 1146.75 |
| September 16, 2024 | 1153.08 |
| September 13, 2024 | 1153.35 |
| September 12, 2024 | 1164.46 |
| September 11, 2024 | 1141.45 |
| September 10, 2024 | 1136.35 |
| September 09, 2024 | 1144.77 |
| September 06, 2024 | 1131.50 |
| September 05, 2024 | 1150.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
336.18
Minimum
Jan 30 2020
1201.76
Maximum
Aug 27 2024
691.24
Average
648.60
Median
Total Return Level Benchmarks
| Amgen Inc | 425.02 |
| Eli Lilly and Co | 2343.87 |
| Pfizer Inc | 95.41 |
| AbbVie Inc | 276.95 |
| Biogen Inc | 165.79 |